Cargando…
NOTCH1 signaling promotes protein stability of HER3 through the AKT pathway in squamous cell carcinoma of head and neck
Epidermal growth factor receptor (EGFR) remains the sole druggable molecular target other than the PD1/PD-L1 pathway with meaningful clinical benefit in squamous cell carcinoma of head and neck (SCCHN). Human epidermal growth factor receptor 3 (HER3) confers the resistance to EGFR-targeted treatment...
Autores principales: | Wang, Yi-Ping, Liu, I-Ju, Chen, Kai-Chi, Wu, Han-Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408252/ https://www.ncbi.nlm.nih.gov/pubmed/34465724 http://dx.doi.org/10.1038/s41389-021-00348-5 |
Ejemplares similares
-
NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma
por: Shah, Pooja A., et al.
Publicado: (2020) -
Multifactorial Contribution of Notch Signaling in Head and Neck Squamous Cell Carcinoma
por: Porcheri, Cristina, et al.
Publicado: (2019) -
Soluble HER-2 in Patients with Head and Neck Squamous Cell Carcinoma
por: Khademi, Bijan, et al.
Publicado: (2013) -
Hypoxia-induced MFAP5 Promotes Tumor Migration and Invasion via AKT Pathway in Head and Neck Squamous Cell Carcinoma
por: Xu, Qiaoshi, et al.
Publicado: (2020) -
KIF18A promotes head and neck squamous cell carcinoma invasion and migration via activation of Akt signaling pathway
por: Liu, Guancheng, et al.
Publicado: (2019)